Medication Assisted Treatment (MAT) for Substance Use Disorder

Substance use disorder is a complex medical condition that affects millions. We understand that effective treatment requires an integrated approach, which leads us to focus on providing evidence-based care to help you find a path to recovery. One of the most effective methods we utilize is Medication Assisted Treatment (MAT).

What is Medication Assisted Treatment?

Medication Assisted Treatment (MAT) is an evidence-based approach for treating opioid use disorder (OUD) and alcohol use disorder (AUD). A comprehensive MAT program combines FDA-approved medications with counseling and behavioral therapies. Research shows this integrated approach is the most effective way to help people achieve and sustain recovery. By addressing both the biological and psychological aspects of addiction, MAT can significantly improve patient outcomes and reduce the risk of relapse.

Who is Medication Assisted Treatment for?

MAT is used to treat two primary conditions: Alcohol Use Disorder (AUD) and Opioid Use Disorder (OUD). It is a highly personalized form of treatment that is not a one-size-fits-all solution. A thorough medical and psychiatric evaluation is required to determine if MAT is the right path for you.

Our Approach to MAT at Rittenhouse Psychiatric Associates

At Rittenhouse Psychiatric Associates, we believe in treating the whole person, not just a singular diagnosis. Our goal is to help you achieve a stable and healthy life by addressing all aspects of your well-being.

Your treatment will begin with a thorough initial psychiatric evaluation, including a complete medical and psychiatric history. We may also recommend blood work. It is incredibly important to evaluate for other co-occurring conditions, such as mood, anxiety, and other medical disorders, that could be making you more vulnerable to addiction.

Our providers will also discuss other aspects of self-care that may be important to your treatment plan, including diet, exercise, yoga/meditation, sleep hygiene, and relationships. While not a requirement, we recommend all patients also be engaged in psychotherapy and a 12-step program, as evidence suggests this significantly increases the likelihood of a successful recovery.

Medication Assisted Treatment for Alcohol Use Disorder

Outpatient care for AUD is not safe for all patients. If you are drinking more than 6 standard drinks per day, are concurrently taking benzodiazepines, or have a history of seizures or withdrawal requiring hospitalization, we will not be able to schedule you until you are stabilized at an inpatient facility.

For stabilized patients, here are the examples of medications we may use as part of your treatment plan:

• Oral Naltrexone: Used to decrease alcohol cravings.
• Disulfiram (Antabuse): This medication blocks an enzyme that breaks down alcohol, causing severe illness if you drink. It can be a very effective way to prevent alcohol use.
• Acamprosate (Campral): This medication works on the brain’s GABA and glutamate pathways to help reduce cravings.
• Long-Acting Injection Naltrexone (Vivitrol): This injectable form can be very effective for decreasing alcohol cravings, even in some cases where oral naltrexone did not achieve the desired effect. We partner with pharmacies throughout Pennsylvania to administer these monthly injections.

Medication Assisted Treatment for Opiate Use Disorder

Some of our providers can treat Opioid Use Disorder with MAT. Scheduling an appointment does not guarantee that a medication will be prescribed, as this type of treatment is not appropriate for all patients. We are happy to collaborate with your treatment team at other facilities (if applicable), to ensure a smooth transition to outpatient care.

Here are examples of medications that may be appropriate for your care:

• Vivitrol (Long-Acting Naltrexone): An injection given every 4 weeks. It requires a waiting period of 10-14 days after the last opiate use to prevent severe withdrawal. We can only prescribe Vivitrol for OUD to patients who reside in, or can come to Pennsylvania, for their appointments and injections.
• Suboxone (Buprenorphine): This sublingual medication (tablet or film) can be used for OUD. It’s not appropriate for all patients and has abuse potential. Patients are required to take it as directed. We do not keep this medication on-site.
• Sublocade and Brixadi (Injectable Buprenorphine): Our providers partner with Pennsylvania pharmacies that can administer this monthly injection. Patients are typically transitioned from a sublingual product (like Suboxone) for 7-10 days before starting the injection to prevent precipitated withdrawal. This can be a very effective option for patients who have difficulty with daily medication compliance. We can only prescribe Sublocade to individuals living in Pennsylvania (or those coming into PA for their appointments).

Our MAT Service: Policies and What to Expect

• Payment & Policies: We do not accept insurance. A credit card is required to schedule an appointment. Pre-payment is required for initial MAT visits for OUD, and we have a strict 48-business-hour cancellation policy.
• Virtual and In-Office Care: We offer both in-office and virtual care options. However, certain treatments, especially injectables, may not be available in every state. Injectables, such as Vivitrol, Sublocade & Brixadi, require patients to come to Pennsylvania for administration by one of our partner pharmacies. We follow state and federal guidelines regarding virtual visits. For the most up-to-date information on your area, call our schedulers.
• Labs and Drug Screens: Urine drug screens are required for care. If you receive virtual care, you will need to identify a local lab that accepts your insurance. Failure to complete these tests within the requested timeframe is grounds for termination of care.
• Controlled Medication Contract: Patients are required to sign a contract for controlled medications. Breaching this contract is grounds for termination of care.

Start Your Medication Assisted Treatment Journey

Taking the first step toward recovery is a courageous choice. Our team at Rittenhouse Psychiatric Associates is here to provide the compassionate support and expert MAT care you need.

Call us at 267-358-6155 or schedule an appointment today and learn how we can help you.

FAQs About Medication Assisted Treatment</h2>

How long does medication-assisted treatment take?

There is no fixed duration for medication-assisted treatment (MAT); its length is highly personalized and depends on an individual’s needs, addiction severity, and progress in recovery. While some programs may last for a few months, many individuals find that staying on medication for a year or longer leads to better outcomes and a decreased risk of relapse.

Does medication-assisted treatment work?

Yes, medication-assisted treatment (MAT) is an effective and evidence-based approach to treating substance use disorders, particularly for opioid and alcohol use disorders. When combined with counseling and behavioral therapies, MAT has been proven to increase treatment retention, reduce the risk of overdose and relapse, and help stabilize brain chemistry.

MAT vs abstinence, which is for me?

The choice between MAT and abstinence is a deeply personal one, and the best path is the one that aligns with your specific needs, health, and goals. MAT is often recommended for individuals who struggle with intense cravings and withdrawal symptoms, as it can significantly increase the chances of long-term recovery, while abstinence-based programs may be a better fit for those who prefer a medication-free approach.